Chiang, F. F., Wang, H. M., & Chen, M. C. Cetuximab plus chemotherapy as first-line treatment for metastatic colorectal cancer: Effect of KRAS mutation on treatment efficacy in Taiwanese patients.
Chicago Style (17th ed.) CitationChiang, F. F., H. M. Wang, and M. C. Chen. Cetuximab Plus Chemotherapy as First-line Treatment for Metastatic Colorectal Cancer: Effect of KRAS Mutation on Treatment Efficacy in Taiwanese Patients.
MLA (9th ed.) CitationChiang, F. F., et al. Cetuximab Plus Chemotherapy as First-line Treatment for Metastatic Colorectal Cancer: Effect of KRAS Mutation on Treatment Efficacy in Taiwanese Patients.
Warning: These citations may not always be 100% accurate.
